FindTrial
Sign In

Polycystic ovarian Syndrome and Homoeopathy

EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN MANAGEMENT AND IMPROVEMENT OF QUALITY OF LIFE AMONG ADULTS WITH POLYCYSTIC OVARIAN SYNDROME A NON CONTROLLED EXPERIMENTAL STUDY - nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091900
Enrollment
48
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Individualised homeopathic medicine: forh 12 month 1.Homoeopathic case format will be used to form a totality with special emphasis on individualizing peculiarities in each case. 2 Ho

Sponsors

Dr Vishal Radahakrishna Dhivar
Lead Sponsor
Dr Swati Bhagwat
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult age. 2.Patient which are clinically pre diagnosed with PCOS according to Rotterdams criteria.

Exclusion criteria

Exclusion criteria: 1. Immuno-compromised patients; 2. Patient with history of adrenal hyperplasia and adrenal tumour; 3. Patient with history of ovarian tumour; 4. Patient with history of Metabolic syndrome or other endocrinal disorder.

Design outcomes

Primary

MeasureTime frame
EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN MANAGEMENT AND IMPROVEMENT OF QUALITY OF LIFE AMONG ADULTS WITH POLYCYSTIC OVARIAN SYNDROMETimepoint: Improvement of the patient will be assessed on follow up every month for 12 month with the comparison of pre and post grade of self assessed scale using Wilcoxon signed rank test & PCOSQOL USING PAIRED t-test for each questionnaire.—

Secondary

MeasureTime frame
Timepoint:—

Countries

India

Contacts

Public ContactDr Swati M Bhagwat
swati_bgagwat_29@yahoo.co.in9969337242

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026